The Fund noted that Hankook Korus, a subsidiary of GL Rapha, has completed the production of an active component for ten million doses of Sputnik Light and is preparing its shipment. The press release added that the RFPI partners in South Korea are preparing to start supplying the world market.
The ceremony for the shipment of the first batch of Sputnik Light will take place shortly with the participation of executives from the RFPI and GL Rapha.
RFPI Director General Kiril Dmitriev plans to participate in the event on a telematic platform, the Fund reported.
Pharmaceutical companies from other countries, in particular from India, China and Argentina, including the Serum Institute of India (one of the world’s largest vaccine producers), signed contracts with the RFPI to manufacture Sputnik vaccines.